Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05716750

Serum Prolidase Activity and the Role of Leptin in Osteomalacia

Conditions: Osteomalacia

Sex: All
Ages: 18 Years – 65 Years
Phase: NA
Enrollment: 38
Sponsor: TUĞBA ŞAHBAZ

Summary

Evaluation of the change of serum Prolidase and Leptin values in the diagnosis and follow-up of osteomalacia and its clinical usability

Eligibility Criteria

Inclusion Criteria:Among the patients who applied to the outpatient clinic, those with clinical complaints of osteomalacia (diffuse pain, fatigue, rapid fatigue, proximal extremity weakness, etc.)25 0H vit. D level of 10ng/ml and belowExclusion Criteria:Other metabolic and endocrine bone diseases (secondary osteoporosis, paget hast, osteogenesis imperfecta, osteomyelitis etc.)Patients who have previously received treatment for low vitamin dThose with low vitamin D levels due to liver or kidney failureThose who receive treatment for tumor

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05716750). StuddyBuddy aggregates publicly available trial information.